ReportWire

Tag: Retail/Wholesale

  • Nordstrom Report Hints at  Weaker Spending by Wealthy Shoppers

    Nordstrom Report Hints at Weaker Spending by Wealthy Shoppers

    [ad_1]

    Nordstrom’s holiday season sales were softer than prepandemic levels, the company said.


    Craig Barritt/Getty Images for Nordstrom

    If
    Nordstrom’s
    latest sales update is anything to go by, high-income shoppers are finally starting to feel the pinch of a slowing economy.

    The luxury department store, whose product lineup is aimed mainly at wealthier people, said late on Thursday that holiday sales were softer than hoped. It is the latest retailer to warn that consumers took a more cautious approach to holiday shopping in 2022.

    “The holiday season was highly promotional, and sales were softer than prepandemic levels,” said CEO Erik Nordstrom in a news release late Thursday. “While we continue to see greater resilience in our higher income cohorts, it is clear that consumers are being more selective with their spending given the broader macro environment.”

    Shares of Nordstrom (ticker:
    JWN
    ) were largely unchanged in early Friday trading, with a gain of 0.1% to $17.47.

    The company also updated its financial forecasts for fiscal 2022, the 12 months ending January 2023. It now expects revenue growth to be at the low end of the range of 5% to 7% it had forecast. Holiday sales fell by 3.5% in 2022, driven by a 7.6% decline in the company’ Nordstrom Rack banner and a 1.7% decrease in core Nordstrom sales.

    Nordstrom also said that the need to sell off outdated inventory weighed heavily on profit and margins. Adjusted earnings per share will range between $1.50 and $1.70, compared with the company’s prior call for $2.30 to $2.60. The consensus call among analysts surveyed by FactSet was for earnings to land at $1.81 for fiscal 2022.

    Adjusted earnings before interest and taxes margin will be 3.1% to 3.3%, compared with the 4.3% to 4.7% management had predicted.

    While costly to the bottom line, discounting heavily during the holiday season may actually be better for Nordstrom in the long run. The company expects year-end inventory levels to be down by a double-digit percentage compared with last year, putting them roughly at 2019 levels.

    “We believe this reduction, coupled with cleaner inventory (~flat to 2019), may actually have been better than feared,” wrote BMO Capital Markets analyst Simon Siegel in a research note. Siegel maintained a Market Perform rating and trimmed his target for the stock price to $20 from $23.

    Still, it isn’t an easy time to be a department store. Nordstrom’s announcement comes weeks after
    Macy’s
    provided investors with a similar update, saying sales would come in at the low to middle end of the range it had forecast as a result of unexpected lulls in demand outside of the peak shopping weekends.

    On Wednesday, the Census Bureau reported that department stores’ retail sales fell by 6.6% in December from November, and were down 0.6% from December 2021.

    Analysts have also expressed concern about what Nordstrom’s guidance means for demand from high-end consumers, whose buying has remained fairly resilient despite macroeconomic challenges.

    For
    Piper Sandler
    ‘s Edward Yruma, who the revision indicates that high-income shoppers may be “undergoing a cyclical slowdown,” driven by layoffs in white-collar industries, a volatile stock market, and a weak housing market. He maintained a Neutral rating on the stock.

    Write to Sabrina Escobar at sabrina.escobar@barrons.com

    [ad_2]

    Source link

  • Bed Bath & Beyond gets Nasdaq delisting warning, stock tumbles 7%

    Bed Bath & Beyond gets Nasdaq delisting warning, stock tumbles 7%

    [ad_1]

    Bed Bath & Beyond Inc. has received a warning that it is not in compliance for continued Nasdaq listing because the company has not yet filed its Form 10-Q quarterly report with the Securities and Exchange Commission.

    In an SEC filing Thursday, the troubled home-goods retailer said it had received the Nasdaq notice on Jan. 12. The notice has no immediate effect on the listing or trading of Bed Bath & Beyond’s
    BBBY,
    -4.09%

    common stock on the Nasdaq
    COMP,
    +0.86%
    ,
    the filing said. “The Notice states that the Company has 60 calendar days from the date of the Notice, or March 13, 2023, to submit a plan to regain compliance with the Listing Rule,” Bed Bath & Beyond said in the filing.

    [ad_2]

    Source link

  • WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating

    WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating

    [ad_1]

    The World Health Organization has called on China to release more information about its current wave of COVID infections after China said nearly 60,000 people have succumbed to the virus since early December, the Associated Press reported. 

    The announcement of fatality numbers on Saturday came after weeks of complaints that China was not keeping experts abreast of what was happening.

    The announcement “allows for a better understanding of the epidemiological situation,” said a WHO statement. Director-general, Tedros Adhanom Ghebreyesus talked by phone with Health Minister Ma Xiaowei, it said.

    “WHO requested that this type of detailed information continued to be shared with us and the public,” the agency said.

    The National Health Commission said only deaths in hospitals were counted, which means anyone who died at home is not part of the tally. It gave no indication of when or whether it might release updated numbers. China has seen a wave of cases ever since the government ended stringent restrictions on movement in December.

    The WHO is now analyzing the data, which covers early December to Jan. 12. So far, the epidemiology is similar to what has been seen in other countries, “a rapid and intense wave of disease caused by known sub-variants of omicron with higher clinical impact on older people and those with underlying conditions,” said the statement.

     The agency is hoping to get more information on the exact variants that are circulating. China has reported that two omicron sublineages, dubbed BA.5.2 and BF.7 are spreading but the WHO needs more sequences to be shared with open databases to get fully up to date.

    See also: China reports first population drop in decades as birthrates plunge

    Tens of thousands of people resumed travels in and out of China on Sunday as the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Some travelers expressed relief to be reunited with their families. Photo: Tyrone Siu/Reuters

    In the U.S., the seven-day average of new U.S. COVID cases stood at 59,121 on Monday, according to a New York Times tracker. That’s flat from two weeks ago and below the recent peak of 70,508 on Christmas Eve.

    See also: Americans are facing years of ‘tripledemic’ winters that may put patients with other ailments at risk, Jha says

    The daily average for hospitalizations was down 8% at 45,052. The average for deaths stood at 562, up 78% from two weeks ago to continue the recent trend.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • The U.S. Centers for Disease Control and Prevention said its real-time surveillance system has met the statistical criteria to prompt additional investigation into whether there is a risk of ischemic stroke in people ages 65 and older who received the Pfizer/BioNTech
    PFE,
    -3.70%

    BNTX,
    -1.28%

    bivalent COVID vaccine. “Rapid-response investigation of the signal in the VSD (vaccine safety datalink) raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-42 following vaccination,” the agency said in a statement. No such signal has been identified with the Moderna
    MRNA,
    -0.68%

    bivalent vaccine, it added.

    • Italian tennis player Camila Giorgi has denied allegations that she obtained a false COVID-19 vaccine certificate to allow her to travel, the AP reported. A doctor is under investigation in Italy for supplying false certificates and fake vaccines and Giorgi’s name was revealed in a long list of people implicated by an Italian newspaper. Giorgi is currently competing in the Australian Open.

    Getting the flu can increase the risk of getting a second infection, including strep throat. WSJ’S Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang

    • The New York State Department of Health is “exploring its options” after a state Supreme Court judge struck down a statewide mandate requiring healthcare workers to be vaccinated against COVID-19, the AP reported separately. Judge Gerard Neri wrote in a ruling released Friday that Democratic Gov. Kathy Hochul and the health department overstepped their authority by mandating a vaccine that’s not included in state public health law, the Syracuse Post-Standard reported. The mandate is “null, void, and of no effect,” the judge said. He sided with Medical Professionals for Informed Consent, a group of medical workers impacted by the vaccination mandate.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 667.3 million on Tuesday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.7 million cases and 1,099,885 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.4 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 49.6 million Americans, equal to 15.9% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • Alibaba, XPeng, Goldman Sachs, and More Stock Market Movers Tuesday

    Alibaba, XPeng, Goldman Sachs, and More Stock Market Movers Tuesday

    [ad_1]


    • Order Reprints

    • Print Article


    [ad_2]

    Source link

  • Personal CFO Solutions LLC Has $629,000 Holdings in Walmart Inc. (NYSE:WMT)

    Personal CFO Solutions LLC Has $629,000 Holdings in Walmart Inc. (NYSE:WMT)

    [ad_1]

    Personal CFO Solutions LLC boosted its holdings in shares of Walmart Inc. (NYSE:WMTGet Rating) by 5.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 4,848 shares of the retailer’s stock after acquiring an additional 261 shares during the quarter. Personal CFO Solutions LLC’s holdings in Walmart were worth $629,000 as of its most recent filing with the Securities & Exchange Commission.

    Other institutional investors have also recently bought and sold shares of the company. Candriam S.C.A. increased its position in Walmart by 398.9% during the second quarter. Candriam S.C.A. now owns 63,636 shares of the retailer’s stock worth $7,736,000 after buying an additional 50,880 shares during the last quarter. Kingsview Wealth Management LLC acquired a new position in shares of Walmart in the second quarter valued at approximately $5,302,000. Windward Capital Management Co. CA grew its position in shares of Walmart by 0.7% in the third quarter. Windward Capital Management Co. CA now owns 28,022 shares of the retailer’s stock valued at $3,634,000 after purchasing an additional 201 shares during the last quarter. Meritage Portfolio Management grew its position in shares of Walmart by 35.2% in the third quarter. Meritage Portfolio Management now owns 20,160 shares of the retailer’s stock valued at $2,615,000 after purchasing an additional 5,253 shares during the last quarter. Finally, Norris Perne & French LLP MI grew its position in shares of Walmart by 6.9% in the third quarter. Norris Perne & French LLP MI now owns 2,989 shares of the retailer’s stock valued at $388,000 after purchasing an additional 194 shares during the last quarter. Institutional investors and hedge funds own 31.27% of the company’s stock.

    Analyst Ratings Changes

    Several equities analysts have recently commented on the company. TheStreet raised Walmart from a “c+” rating to a “b” rating in a research report on Thursday, September 29th. Cowen upped their target price on Walmart from $165.00 to $175.00 in a research report on Wednesday, November 16th. DA Davidson upped their target price on Walmart from $163.00 to $173.00 and gave the company a “buy” rating in a research report on Wednesday, November 16th. Cowen upped their target price on Walmart from $165.00 to $175.00 and gave the company an “outperform” rating in a research report on Wednesday, November 16th. Finally, JPMorgan Chase & Co. set a $155.00 target price on Walmart in a research report on Wednesday, November 16th. One analyst has rated the stock with a sell rating, nine have given a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $160.52.

    Insider Activity

    In other news, EVP John R. Furner sold 4,375 shares of the stock in a transaction on Thursday, October 27th. The stock was sold at an average price of $140.94, for a total value of $616,612.50. Following the completion of the transaction, the executive vice president now directly owns 263,809 shares in the company, valued at approximately $37,181,240.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP John R. Furner sold 4,375 shares of the stock in a transaction on Thursday, October 27th. The stock was sold at an average price of $140.94, for a total value of $616,612.50. Following the completion of the transaction, the executive vice president now directly owns 263,809 shares in the company, valued at approximately $37,181,240.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director S Robson Walton sold 350,000 shares of the stock in a transaction on Friday, December 23rd. The shares were sold at an average price of $143.31, for a total value of $50,158,500.00. Following the completion of the sale, the director now owns 267,693,635 shares of the company’s stock, valued at $38,363,174,831.85. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,831,902 shares of company stock worth $1,312,822,421. Insiders own 47.06% of the company’s stock.

    Walmart Stock Up 0.3 %

    NYSE WMT opened at $145.29 on Friday. The business has a fifty day moving average price of $146.42 and a two-hundred day moving average price of $137.25. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.86 and a quick ratio of 0.23. Walmart Inc. has a fifty-two week low of $117.27 and a fifty-two week high of $160.77. The stock has a market capitalization of $391.82 billion, a PE ratio of 44.84, a PEG ratio of 4.35 and a beta of 0.54.

    Walmart (NYSE:WMTGet Rating) last announced its quarterly earnings results on Tuesday, November 15th. The retailer reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.32 by $0.18. Walmart had a return on equity of 19.54% and a net margin of 1.49%. The company had revenue of $152.80 billion during the quarter, compared to analysts’ expectations of $146.80 billion. During the same period in the prior year, the company earned $1.45 EPS. Walmart’s revenue was up 8.8% compared to the same quarter last year. Equities analysts expect that Walmart Inc. will post 6.08 earnings per share for the current fiscal year.

    Walmart announced that its board has authorized a share buyback plan on Tuesday, November 15th that authorizes the company to repurchase $20.00 billion in shares. This repurchase authorization authorizes the retailer to repurchase up to 5% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.

    Walmart Company Profile

    (Get Rating)

    Walmart Inc engages in the operation of retail, wholesale, and other units worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam’s Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores; membership-only warehouse clubs; ecommerce websites, such as walmart.com, walmart.com.mx, walmart.ca, flipkart.com, and samsclub.com; and mobile commerce applications.

    Further Reading

    Want to see what other hedge funds are holding WMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walmart Inc. (NYSE:WMTGet Rating).

    Institutional Ownership by Quarter for Walmart (NYSE:WMT)

    Receive News & Ratings for Walmart Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walmart and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link

  • Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

    Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

    [ad_1]

    Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon.

    With reality setting in, it’s a buyer’s market for companies looking for acquisitions and partnerships, according to many of the pharmaceutical and medical technology executives who gathered at this year’s


    J.P. Morgan


    healthcare investor conference, which wrapped up in San Francisco on Thursday.

    [ad_2]

    Source link

  • New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says

    New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says

    [ad_1]

    The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update from the Centers for Disease Control and Prevention early Friday.

    XBB.1.5 accounted for 43% of all COVID cases in the week through Jan. 14, pulling ahead of BQ.1.1, which accounted for 28.8% of new cases, and BQ.1, which accounted for 15.9%, the data showed.

    Last week, BQ.1.1 was still dominant nationwide, accounting for 33.5% of new cases versus XBB.1.5’s 30.4%.

    In the New York region, which includes New Jersey, the U.S. Virgin Islands and Puerto Rico, XBB.1.5 now accounts for 82.7% of new cases, up from 72.7% a week ago.

    On Thursday, the World Health Organization acknowledged that XBB.1.5, which was first detected in tiny numbers in the U.S. in October, has become the most transmissible variant yet thanks to a growth advantage, and said that it appears to have a greater ability to evade immunity than earlier variants.

    However, the immune-escape data is based on preliminary lab-based studies and not on research in humans. And with the only data to review coming from the U.S., the agency said there’s no information yet on clinical severity.

    XBB.1.5 is similar to its immediate predecessor XBB.1 but has an additional mutation to its spike protein that may be behind its growth advantage. For now, it does not appear to have any mutation that might lead to more severe disease or death, WHO officials have said. The agency is monitoring it along with five other omicron variants.

    On Friday, the WHO updated guidelines on face masks, treatments and patient care in the age of COVID, a reminder that the pandemic is not yet over, even if people are mostly behaving as if it is. Given current global trends, the agency is recommending that people wear face masks when in public settings that are enclosed or poorly ventilated. People who have been exposed to the virus should also wear masks.

    “Similar to previous recommendations, WHO advises that there are other instances when a mask may be suggested, based on a risk assessment,” the agency said in a statement. “Factors to consider include the local epidemiological trends or rising hospitalization levels, levels of vaccination coverage and immunity in the community, and the setting people find themselves in.”

    The WHO reduced its recommended isolation period for COVID patients and said they can end isolation early if they test negative on a rapid test. Patients with symptoms should isolate for 10 days from the start of symptom onset, but the agency has dropped its advice for an additional three days.

    For asymptomatic patients who test positive, the WHO now recommends five days of isolation, compared with 10 days previously.

    The WHO extended a strong recommendation for the use of Pfizer’s
    PFE,
    +0.29%

    antiviral Paxlovid for patients with mild to moderate symptoms who are at risk of hospitalization.

    The data comes as the seven-day average of new U.S. cases stood at 60,610 on Thursday, according to a New York Times tracker. That’s up 4% from two weeks ago and below the recent peak of 70,508 on Christmas Eve. The daily average for hospitalizations was up 10% to 45,842. The average for deaths was 564, up 61% from two weeks ago. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • The peak of China’s COVID-19 wave is expected to last two to three months and to soon extend over the country’s vast rural areas, where medical resources are relatively scarce, Reuters reported Friday, citing a Chinese epidemiologist. Infections are expected to surge in those areas as hundreds of millions of people travel to their hometowns for the Lunar New Year holiday, which starts Jan. 21. “Our priority focus has been on the large cities. It is time to focus on rural areas,” said Zeng Guang, the former chief epidemiologist at the Chinese Centers for Disease Control and Prevention, according to a report published in local media outlet Caixin on Thursday.

    • Private services offering Chinese travelers access to mRNA vaccines are attracting droves of mainlanders to Hong Kong and Macau, the Guardian reported on Friday, as people seek a booster shot that their government has refused to approve. The government only allowed its citizens to get homegrown vaccines developed by Sinopac and Sinopharm
    8156,
    +6.45%

    throughout the pandemic, but many people are now seeking the greater protection offered by the mRNA vaccines developed by Moderna
    MRNA,
    +2.10%

    and by Pfizer and German partner BioNTech
    BNTX,
    -2.92%
    .

    Tens of thousands of people have resumed travels in and out of China after the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Photo: Tyrone Siu/Reuters

    • Kansas Gov. Laura Kelly plans to return to work at the Statehouse Friday after learning that a COVID-19 test earlier in the week gave her a false positive result, her office said, the Associated Press reported. Kelly has been working in self-isolation at the governor’s residence since the false positive Tuesday. Her office announced that she had tested positive for COVID-19, and she postponed the annual State of the State address from Wednesday to Jan. 24.

    See also: Sick house: Florida man gets 8 ½ years for using COVID relief to buy lavish 12-acre estate, fleet of luxury cars

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 666.3 million on Friday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.6 million cases and 1,099,629 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.4 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 49.6 million Americans, equal to 15.9% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • J Sainsbury sees 2023 profit toward upper end of views on robust Christmas period

    J Sainsbury sees 2023 profit toward upper end of views on robust Christmas period

    [ad_1]

    J Sainsbury PLC said Wednesday that it expects to deliver profits for fiscal 2023 toward the upper end of its current guidance following record trading during the Christmas period.

    The U.K. grocer
    SBRY,
    -3.09%

    said like-for-like sales excluding fuel rose 5.9% in the 16 weeks ended Jan. 7 compared with the same period a year ago. Like-for-like sales including fuel rose 6.8%, it said.

    The FTSE 100 listed company currently expects underlying pretax profit for the year ending March to be toward the upper end of the guidance range of between 630 million pounds and 690 million pounds ($765.5 million and $838.4 million).

    The company said the performance of its digital retailer business Argos was exceptional over the Christmas week.

    Write to Michael Susin at michael.susin@wsj.com

    [ad_2]

    Source link

  • 18 stock picks in a ‘Goldilocks’ scenario for U.S. consumers

    18 stock picks in a ‘Goldilocks’ scenario for U.S. consumers

    [ad_1]

    It may not have been a surprise to see the consumer discretionary sector of the S&P 500 get hammered last year amid talk of a looming recession while the Federal Reserve jacked up interest rates to push back against inflation.

    But the stock market always looks ahead. Following a decline of 19.4% for the S&P 500
    SPX,
    +0.42%

    in 2022 and a 37.6% drop for the benchmark index’s consumer discretionary sector, this may be the time to begin looking for bargains.

    And now, analysts at Jefferies have lifted the sector to a “bullish” rating.

    In a note to clients on Jan. 10, Jefferies’ global equity strategist, Sean Darby, wrote: “A Goldilocks scenario might be unfolding for the U.S. consumer — falling inflation but steady employment conditions.”

    He sees consumer confidence improving, in part because “households are still sitting on [about] $1.4 trillion of Covid savings.”

    Darby pointed to a list of 18 consumer discretionary stocks favored by Jefferies analysts that was published on Jan. 6. Those are listed below, along with three stocks in the sector the analysts rate “underperform.”

    The ratings of the Jefferies analysts for individual stocks is based on their 12-month outlooks for the companies, in keeping with Wall Street tradition.

    So we have added another list further down, showing which companies in the S&P 500 consumer discretionary sector are expected by analysts polled by FactSet to increase sales the most through 2024.

    The Jefferies 18

    Here are the 18 consumer discretionary stocks recommended by Jefferies analysts with “buy” ratings on Jan. 6, sorted by how much upside the firm sees for the shares from closing prices on Jan. 9:

    Company

    Ticker

    Jan. 9 price

    Jefferies price target

    Implied 12-month upside potential

    Three-year estimated sales CAGR through 2022

    Two-year estimated sales CAGR through 2024

    Topgolf Callaway Brands Corp.

    MODG,
    -0.22%
    $20.76

    $56

    170%

    32.8%

    10.0%

    Bloomin’ Brands Inc.

    BLMN,
    +3.87%
    $22.08

    $35

    59%

    2.4%

    3.7%

    Coty Inc. Class A

    COTY,
    +1.23%
    $9.38

    $14

    49%

    -7.1%

    3.7%

    MGM Resorts International

    MGM,
    +1.71%
    $37.64

    $56

    49%

    -0.1%

    6.6%

    Chewy Inc. Class A

    CHWY,
    +1.63%
    $40.13

    $57

    42%

    28.0%

    10.6%

    Planet Fitness Inc. Class A

    PLNT,
    +0.69%
    $82.36

    $115

    40%

    10.4%

    13.9%

    Molson Coors Beverage Co. Class B

    TAP,
    +0.67%
    $50.21

    $69

    37%

    0.5%

    1.4%

    Fox Factory Holding Corp.

    FOXF,
    +3.95%
    $99.90

    $135

    35%

    28.1%

    6.6%

    Hasbro Inc.

    HAS,
    +0.99%
    $63.70

    $85

    33%

    9.1%

    3.6%

    Hostess Brands Inc. Class A

    TWNK,
    +0.33%
    $23.10

    $30

    30%

    14.2%

    5.0%

    Lowe’s Cos. Inc.

    LOW,
    +0.08%
    $199.44

    $250

    25%

    10.6%

    -1.9%

    Walmart Inc.

    WMT,
    -0.27%
    $144.95

    $175

    21%

    4.9%

    3.3%

    Dollar General Corp.

    DG,
    -0.26%
    $241.05

    $285

    18%

    10.9%

    6.7%

    Church & Dwight Co. Inc.

    CHD,
    -1.17%
    $82.25

    $97

    18%

    7.0%

    4.6%

    McDonald’s Corp.

    MCD,
    +0.39%
    $267.25

    $315

    18%

    2.4%

    4.0%

    Estee Lauder Cos. Inc. Class A

    EL,
    +0.39%
    $261.63

    $304

    16%

    2.8%

    5.8%

    Mondelez International Inc. Class A

    MDLZ,
    -0.04%
    $67.24

    $75

    12%

    6.3%

    4.1%

    Tapestry Inc.

    TPR,
    +0.73%
    $41.25

    $45

    9%

    3.3%

    3.2%

    Sources: Jefferies, FactSet

    Click on the tickers for more information about the companies.

    Click here for Tomi Kilgore’s detailed guide to the wealth of information available for free on the MarketWatch quote page.

    The two right-most columns on the table show estimated compound annual growth rates (CAGR) for the companies over the past three calendar years and expected sales CAGR for two years through calendar 2024, based on the companies’ financial reports and consensus estimates among analysts polled by FactSet.

    (We used calendar-year numbers, some of which are estimated by FactSet for prior years, because some companies have fiscal years or even months that don’t match the calendar.)

    The stock pick with the highest 12-month upside potential, based on Jefferies’ price target, is Topgolf Callaway Brands Corp.
    MODG,
    -0.22%
    .
    This company has the highest estimated three-year sales CAGR on the list, and has the third-highest projected sales CAGR through 2024, after Planet Fitness Inc.
    PLNT,
    +0.69%

    and Chewy Inc.
    CHWY,
    +1.63%
    .

    On Jan. 6, the Jefferies analysts also listed three stocks in the sector they rated “underperform.” Here they are, sorted by how much the analysts expect the stocks to decline over the next 12 months:

    Company

    Ticker

    Jan. 9 price

    Jefferies price target

    Implied 12-month upside potential

    Three-year estimated sales CAGR through 2022

    Two-year estimated sales CAGR through 2024

    Lululemon Athletica Inc.

    LULU,
    +2.98%
    $298.66

    $200

    -33%

    26.3%

    14.6%

    Williams-Sonoma Inc.

    WSM,
    +1.75%
    $122.17

    $98

    -20%

    14.1%

    -0.3%

    Harley-Davidson Inc.

    HOG,
    +0.35%
    $43.25

    $39

    -10%

    -2.8%

    4.4%

    Sources: Jefferies, FactSet

    Screen of consumer discretionary sales growth

    A look head at which companies are expected to increase sales the most over the next two years might serve as a good starting point for your own research.

    Bear in mind that some of the companies in travel-related industries suffered declining sales for three years through 2022 because of the coronavirus pandemic. Some of those are on this new list of 20 stocks in the S&P 500 consumer discretionary sector expected to show the highest two-year sales CAGR through calendar 2024:

    Company

    Ticker

    Two-year estimated sales CAGR through 2024

    Three-year estimated sales CAGR through 2022

    Share “buy” ratings

    Jan. 9 price

    Consensus price target

    Implied 12-month upside potential

    Las Vegas Sands Corp.

    LVS,
    +1.59%
    59.2%

    -32.6%

    79%

    $52.78

    $53.53

    1%

    Norwegian Cruise Line Holdings Ltd.

    NCLH,
    +1.67%
    39.6%

    -9.3%

    44%

    $13.78

    $16.96

    23%

    Carnival Corp.

    CCL,
    +1.64%
    35.2%

    -14.7%

    30%

    $9.47

    $10.11

    7%

    Tesla Inc.

    TSLA,
    -1.83%
    34.3%

    49.7%

    64%

    $119.77

    $232.43

    94%

    Wynn Resorts Ltd.

    WYNN,
    +2.01%
    29.3%

    -17.5%

    53%

    $94.33

    $96.07

    2%

    Royal Caribbean Group

    RCL,
    +2.22%
    28.4%

    -6.8%

    53%

    $57.29

    $66.43

    16%

    Chipotle Mexican Grill Inc.

    CMG,
    -0.17%
    13.4%

    15.9%

    71%

    $1,446.74

    $1,778.81

    23%

    Amazon.com Inc.

    AMZN,
    +2.61%
    12.2%

    22.1%

    92%

    $87.36

    $133.76

    53%

    Booking Holdings Inc.

    BKNG,
    +0.37%
    11.9%

    3.9%

    63%

    $2,208.41

    $2,307.67

    4%

    Aptiv PLC

    APTV,
    +1.66%
    11.9%

    6.4%

    70%

    $97.98

    $117.23

    20%

    Starbucks Corp.

    SBUX,
    +1.28%
    11.2%

    7.2%

    42%

    $104.74

    $103.44

    -1%

    Etsy Inc.

    ETSY,
    +3.56%
    11.1%

    45.3%

    50%

    $120.99

    $124.04

    3%

    Hilton Worldwide Holdings Inc.

    HLT,
    +0.06%
    10.1%

    -2.9%

    38%

    $129.08

    $146.17

    13%

    Expedia Group Inc.

    EXPE,
    +0.39%
    9.0%

    -0.9%

    50%

    $93.77

    $125.65

    34%

    NIKE Inc. Class B

    NKE,
    +0.68%
    8.1%

    5.8%

    62%

    $124.85

    $126.15

    1%

    Marriott International Inc. Class A

    MAR,
    +0.47%
    7.5%

    -1.2%

    30%

    $152.53

    $172.81

    13%

    BorgWarner Inc.

    BWA,
    +1.82%
    7.1%

    15.3%

    53%

    $42.24

    $46.93

    11%

    Tractor Supply Co.

    TSCO,
    +1.06%
    6.8%

    19.0%

    61%

    $217.48

    $232.34

    7%

    Yum! Brands Inc.

    YUM,
    -0.76%
    6.7%

    6.4%

    47%

    $129.76

    $137.79

    6%

    Dollar General Corp.

    DG,
    -0.26%
    6.7%

    10.9%

    67%

    $241.05

    $267.54

    11%

    Source: FactSet

    Among the companies on this list that didn’t suffer sales declines from 2019 levels, Tesla Inc.
    TSLA,
    -1.83%

    is expected to achieve the highest two-year sales CAGR through 2022.

    Dollar General Corp.
    DG,
    -0.26%

    is the only company to appear on this list based on consensus sales growth estimates and the Jefferies recommended list.

    Don’t miss: These 15 Dividend Aristocrat stocks have been the best income builders

    [ad_2]

    Source link

  • China takes first steps to punish countries that imposed testing mandates for Chinese travelers

    China takes first steps to punish countries that imposed testing mandates for Chinese travelers

    [ad_1]

    China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements for Chinese travelers, the Associated Press reported.

    No other details were given, although China has threatened to retaliate against countries that require travelers from China to show a negative result for a test taken within the previous 48 hours.

    That has not stopped about a dozen countries from following the U.S. in requiring Chinese travelers produce a test after China lifted most of its strict COVID-related restrictions for the first time since the start of the pandemic. The end of those restrictions has resulted in a surge of new cases.

    The World Health Organization and several nations have accused China of withholding data on its outbreak. The testing requirements are aimed at identifying potential virus variants carried by travelers.

    Separately on Tuesday, the head of the WHO for Europe said the surge of cases in China is not likely to have a big impact on Europe, although he cautioned against complacency.

    Hans Kluge told reporters it was “not unreasonable for countries to take precautionary measures to protect their populations” but called for such measures “to be rooted in science, to be proportionate and nondiscriminatory,” as AFP reported.

    Tens of thousands of people resumed travels in and out of China after the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Photo: Tyrone Siu/Reuters

    In the U.S., the seven-day average of new cases stood at 67,012 on Monday, according to a New York Times tracker. That’s up 2% from two weeks ago and below the recent peak of 70,508 on Christmas Eve.

    The daily average for hospitalizations was up 18% to 47,503. The average for deaths was 467, up 10% from two weeks ago. 

    Cases are currently rising in 21 states, along with Guam, Washington, D.C., and the U.S. Virgin Islands. They are led by Florida, where cases are up 90% from two weeks ago. On a per-capita basis, New York, New Jersey and Rhode Island are seeing the highest rates. New York has 37 cases per 100,000 people, New Jersey 35 and Rhode Island 31.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Thailand sent three cabinet ministers to welcome Chinese tourists with flowers and gifts as they arrived Monday at Bangkok’s Suvarnabhumi Airport after China relaxed travel restrictions, the AP reported. The high-profile event reflected the importance Thailand places on wooing Chinese travelers to help restore its pandemic-battered tourism industry. Before COVID, Chinese visitors accounted for about one-third of all arrivals.

    • Moderna Inc.
    MRNA,
    +3.10%

    is considering pricing its COVID vaccine at $110 to $130 per dose, the Wall Street Journal reported. That’s the same price range as mooted by Pfizer Inc.
    PFE,
    -1.59%

    and German partner BioNTech SE
    BNTX,
    +3.30%

    once their vaccine moves to the commercial market. For now, vaccines are being purchased and distributed by the U.S. government.

    Getting the flu can increase the risk of getting a second infection, such as strep throat. The Wall Street Journal’s Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang

    • India has detected the presence of all the COVID omicron subvariants in the community after testing more than 300 samples since late December, the health ministry said in a statement, Reuters reported. “No mortality or rise in transmission were reported in the areas where these variants were detected,” the ministry said.

    [ad_2]

    Source link

  • Bed Bath & Beyond’s Q3 earnings fall below estimates as loss widens and same-store sales fell 32%

    Bed Bath & Beyond’s Q3 earnings fall below estimates as loss widens and same-store sales fell 32%

    [ad_1]

    Bed Bath & Beyond Inc.
    BBBY,
    +23.66%

    said Tuesday it had a net loss of $392.9 million, or $4.33 a share, for its fiscal third quarter to Nov. 26, wider than the loss of $276.4 million, or $2.78 a share, posted in the year-earlier period. The company’s adjusted loss per share came to $3.85, wider than the $2.61 FactSet consensus. Sales fell to $1.259 billion from $1.878 billion a year ago, also below the $1.314 billion FactSet consensus. Sales were hurt by a slump in same-store sales of 32%, wider than the FactSet consensus for a decline of 25.9%. The troubled retailer, which said last week it may have to file for bankruptcy, said it is exploring all strategic alternatives and will keep investors updated in a timely manner. “We want our customers to know that we hear them and are charging ahead every day to meet their needs,” CEO Sue Gove said in a statement. “Our entire organization is laser-focused on maximizing the value of our company by reconnecting with our customers and positioning Bed Bath & Beyond, buybuy BABY, and Harmon for long-term success.” The stock was flat premarket, but has fallen 88% in the last 12 months, while the S&P 500
    SPX,
    -0.08%

    has fallen 17%.

    [ad_2]

    Source link

  • Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response

    Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response

    [ad_1]

    A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023.

    That’s down from $18.4 billion in sales in 2022. The company plans to boost spending on research and development to $4.5 billion this year, up from $3.3 billion in 2022.

    Moderna
    MRNA,
    +1.79%

    provided the update in advance of the company’s presentation at the annual J.P. Morgan Healthcare Conference in San Francisco.

    Separately, CureVac
    CVAC,
    +24.46%

     said preliminary data from its early stage trial for its COVID and seasonal flu shots had positive results to advance to the next stage of clinical testing.

    CureVac is developing the shots with GlaxoSmithKline
    GSK,
    -0.79%

     
    GSK,
    -0.75%
    .
     CureVac said the shot was well tolerated, and that neutralizing antibodies were beginning at the lowest tested dose for younger adults. The seasonal flu shot was also well tolerated with an increase in antibodies compared to those from a flu vaccine comparator in younger adults, CureVac said.

    Ocugen announced positive results in a trial of its COVID vaccine Covaxin, which uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades. The Phase 2/3 trial involved 491 U.S. adult participants who received two doses of Covaxin or placebo 28 days apart.

    “Covaxin, an inactivated virus vaccine adjuvanted with TLR7/8 agonist, has been demonstrated in clinical trials to generate a broader immune response against the whole virus covering important antigens such as S-protein, RBD, and N-protein; whereas currently approved vaccines in the U.S. target only S-protein antigen,” the company said in a statement.

    Chief Executive Dr. Shankar Musnuri said the company is hoping the vaccine will offer an option for those who are still hesitant to take an mRNA vaccine, which uses newer technology.

    U.S. cases were lower on Sunday, according to a New York Times tracker. The seven-day average of new cases stood at 67,246, down 1% from two weeks ago.

    The daily average for hospitalizations was up 18% at 47,500., the highest level since last March. The average for deaths was 509, up 19% from two weeks ago.

    Hospitalizations are becoming concerning, according to the Times trackers, with the Northeast seeing the highest per capita rates, along with the Southeast.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • China has suspended or closed the social-media accounts of more than 1,000 critics of the government’s COVID response, as the country rolls back harsh anti-virus restrictions and gears up for the coming Lunar New Year holiday, the Associated Press reported. The popular Sina Weibo social media platform said it had addressed 12,854 violations including attacks on experts, scholars and medical workers and issued temporary or permanent bans on 1,120 accounts. The ruling Communist Party had largely relied on the medical community to justify its tough lockdowns, quarantine measures and mass testing, almost all of which it abruptly abandoned last month, leading to a surge in new cases that have stretched medical resources to their limits. The party allows no direct criticism and imposes strict limits on free speech.

    Tens of thousands of people resumed travels in and out of China on Sunday as the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Some travelers expressed relief to be reunited with their families. Photo: Tyrone Siu/Reuters

    • Pfizer’s
    PFE,
    -4.77%

    antiviral Paxlovid has not been included in the Chinese government’s national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive, the AP reported separately. Although it is supposed to be prescribed by medical professionals, that hasn’t stopped people from scrambling to purchase it on their own through any means at their disposal—including buying generic Indian versions of the drug through the internet, according to local media reports.

    • The union representing a group of nurses at a New York City hospital reached a tentative contract agreement with its management, but close to 9,000 nurses at several other major hospitals were still preparing to go on strike, the AP reported. The New York State Nurses Association and BronxCare Health System said Saturday that a tentative agreement had been reached; the union said it included pay raises every year of its three-year term as well as staffing increases. Another hospital, Flushing Hospital Medical Center, got to a tentative agreement with nurses on Friday evening.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 664.3 million on Monday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.2 million cases and 1,096,523 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.3 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 48.2 million Americans, equal to 15.4% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • SEC charges ex–McDonald’s CEO Easterbrook for making false statements relating to his 2019 ouster

    SEC charges ex–McDonald’s CEO Easterbrook for making false statements relating to his 2019 ouster

    [ad_1]

    The Securities and Exchange Commission said Monday it has filed charges against Stephen J. Easterbrook, former chief executive of McDonald’s Corp., for making “false and misleading” statements to investors about the circumstances that led to his ouster in November 2019.

    The agency has also filed charges against McDonald’s for “shortcomings” in its public disclosures relating to Easterbrook’s severance agreement.

    McDonald’s
    MCD,
    -0.55%

    fired Easterbrook for exercising poor judgment and violating company policy by engaging in an inappropriate personal relationship with a McDonald’s employee. However, the separation agreement struck with the executive concluded that his termination was without cause, allowing him to retain substantial equity compensation that would have been forfeited in other circumstances.

    “In making this conclusion, McDonald’s exercised discretion that was not disclosed to investors,” the SEC said in a statement.

    In July 2020, McDonald’s discovered in an internal probe that Easterbrook had engaged in other, undisclosed relationships with employees. Those findings were not disclosed prior to Easterbrook’s termination, in the knowledge that they would influence the board’s decision making, according to the SEC.

    “When corporate officers corrupt internal processes to manage their personal reputations or line their own pockets, they breach their fundamental duties to shareholders, who are entitled to transparency and fair dealing from executives,” said Gurbir S. Grewal, the SEC’s director of the division of enforcement. 

    The SEC is charging Easterbrook with violating anti-fraud provisions of the SEC Securities Act of 1933 and the Securities Exchange Act of 1934. Easterbrook has consented to a cease-and-desist order and five-year officer and director bar and a $400,000 civil penalty, without admitting to or denying the charges.

    McDonald’s is charged with violating section 14(a) of the Exchange Act and Exchange Act Rule 14a-3. The fast-food giant has consented to a cease-and-desist order, without admitting to or denying SEC findings. The SEC has opted not to fine the company, as it cooperated with the agency and clawed back compensation after its probe.

    The stock was slightly lower Monday in early trades.

    [ad_2]

    Source link

  • UPDATE: Lululemon stock slides premarket after yoga gear maker revises Q4 guidance

    UPDATE: Lululemon stock slides premarket after yoga gear maker revises Q4 guidance

    [ad_1]

    Lululemon Athletica Inc.
    LULU,
    +1.02%

    revised its fourth-quarter guidance on Monday by raising its revenue guidance. tweaking its per-share earnings guidance to a tighter range and lowering margin guidance. The yoga wear company now expects revenue to range from $2.660 billion to $2.700 billion, up from prior guidance of $2.605 billion to $2.655 billion. It expects EPS of $4.22 to $4.27 compared with prior guidance of $4.20 to $4.30. The company expects gross margins to decline 90 basis points to 110 basis points, compared with prior guidance of a rise of 10 basis points to 20 basis points. “However, the company now expects that it will further leverage selling, general and administrative expenses 100-120 basis points compared to its previous expectation of 30-50 basis points of leverage,” the company said in a statement released ahead of an investor conference. Lululemon stock slid 12% premarket, and is down 7% in the last 12 months through Friday’s close, while the S&P 500
    SPX,
    +2.28%

    has fallen 17%. Under Armour stock
    UA,
    +3.70%

    and Nike Inc.
    NKE,
    +3.24%

    fell in sympathy, The former was down 2.6% premarket and Nike was down 1.5%.

    [ad_2]

    Source link

  • Alibaba shares rise in Hong Kong after Jack Ma cedes control of Ant Group

    Alibaba shares rise in Hong Kong after Jack Ma cedes control of Ant Group

    [ad_1]

    Shares of Alibaba Group Holdings are higher following news that co-founder Jack Ma is ceding control of affiliate company Ant Group Co., potentially paving the way to revive plans for an initial public offering by the fintech giant.

    Alibaba’s Hong Kong-listed shares
    9988,
    +7.78%

    advanced as much as 8.3% in early trade Monday, widening its year-to-date gains to 27%. Shares are outperforming a 1.7% gain in the city’s broader Hang Seng Index
    HSI,
    +1.65%

    and helping lift the city’s tech index by 3.0%. Alibaba is a shareholder of Ant.

    Ant, which owns China’s most widely used digital-payment platform, Alipay, has been overhauling its operations amid a government crackdown that began with Beijing calling off the company’s plans for an IPO in late 2020. The new change of control, announced by Ant over the weekend, moves the company a step closer to restructuring.

    Alibaba added Sunday that its equity interest in Ant remains unchanged.

    Shares of Alibaba were last up 7.6%. Shares of unit Alibaba Health Information Technology Ltd.
    241,
    +7.27%

    were 8.0% higher.

    [ad_2]

    Source link

  • Jack Ma Cedes Control of Fintech Giant Ant Group

    Jack Ma Cedes Control of Fintech Giant Ant Group

    [ad_1]

    Jack Ma Cedes Control of Fintech Giant Ant Group

    [ad_2]

    Source link

  • Macy’s stock slides as holiday lulls weigh on sales forecast and execs predict difficulties into 2023

    Macy’s stock slides as holiday lulls weigh on sales forecast and execs predict difficulties into 2023

    [ad_1]

    Shares of department-store chain Macy’s Inc. slid 8% in after-hours trading on Friday after the retailer gave a more downbeat forecast on its fourth-quarter sales, with management citing big “lulls” in the holiday-shopping season and saying customers would likely feel the squeeze from inflation into next year.

    Executives said they expected those sales to land in the “low-end to mid-point” of prior expectations for between $8.161 billion to $8.401 billion. They said they expected adjusted earnings per share to be within its previously forecast range of $1.47 to $1.67.

    “Black Friday/Cyber Monday sales were in line with our expectations, while the week leading up to and following Christmas were ahead,” Macy’s
    M,
    +2.64%

    Chief Executive Jeff Gennette said in a statement. “However, the lulls of the non-peak holiday weeks were deeper than anticipated.”

    “Based on current macro-economic indicators and our proprietary credit card data,” he continued, “we believe the consumer will continue to be pressured in 2023, particularly in the first half, and have planned inventory mix and depth of initial buys accordingly.”

    Macy’s issued the sales and profit figures as Wall Street parses consumer behavior during the holiday season. Adobe on Thursday said online sales surpassed $210 billion and beat expectations. Costco Wholesale Corp., a day earlier, reported an increase in December sales, even though online sales fell.

    [ad_2]

    Source link

  • Costco stock rises as holiday sales gain even as online sales recede

    Costco stock rises as holiday sales gain even as online sales recede

    [ad_1]

    Costco Wholesale Corp. shares ticked higher in the extended session Thursday after the warehouse club reported a rise in holiday sales from a year ago, even as online sales pulled back.

    Costco
    COST,
    -1.40%

    said December sales rose 7% to $23.8 billion, up from $22.24 billion a year ago.

    For the 18 weeks ending Jan. 1, sales rose 7.6% to $81.16 billion, up from $76.34 billion in the year-ago period.

    While same-store sales grew for each period, e-commerce sales declined. Total company same-store sales rose 5.5% for the month and 6.1% for the 18 weeks ending Jan. 1., while e-commerce sales declined 6.4% and 4.8%, respectively.

    Costco shares rose more than 2% after hours, following a 1.4% decline to close the regular session at $450.19.

    [ad_2]

    Source link

  • Amazon confirms more than 18,000 layoffs, far more than originally expected

    Amazon confirms more than 18,000 layoffs, far more than originally expected

    [ad_1]

    Amazon.com Inc.’s
    AMZN,
    -0.79%

    layoffs will affect more than 18,000 employees, the highest reduction tally revealed in the past year at a major technology company as the industry pares back amid economic uncertainty.

    The Seattle-based company in November said that it was beginning layoffs among its corporate workforce, with cuts concentrated on its devices business, recruiting and retail operations. At the time, The Wall Street Journal reported the cuts would total about 10,000 people. Thousands of those cuts began last year.

    [ad_2]

    Source link